Assessing goodness‐of‐fit for evaluation of dose‐proportionality-Reference-Cited by-同舟云学术

Assessing goodness‐of‐fit for evaluation of dose‐proportionality

Published:2020-10-15 Issue:2 Volume:20 Page:272-281
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Wolfsegger Martin J.¹^ORCID,Bauer Alexander¹,Labes Detlew²^ORCID,Schütz Helmut³^ORCID,Vonk Richardus⁴,Lang Benjamin⁵,Lehr Stephan⁶,Jaki Thomas F.⁷^ORCID,Engl Werner¹,Hale Michael D.⁸

Affiliation:

1. Baxalta Innovations GmbH, a Takeda company Vienna Austria

2. Consultant Berlin Germany

3. BEBAC – Consultancy Services for Bioequivalence and Bioavailability Studies Vienna Austria

4. Bayer AG Berlin Germany

5. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany

6. Austrian Medicines and Medical Devices Agency Wien Austria

7. Department of Mathematics and Statistics Lancaster University Lancaster UK

8. Shire, a Takeda company Lexington Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2074

Reference22 articles.

1. Analysis of dose proportionality testing methods in phase I clinical trials of anticancer agents;Calvo E;Cancer Res,2005

2. Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion

3. Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party

4. Statistical Issues in Drug Development

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis;Pharmaceuticals;2024-06-11

2. Variability and uncertainty: interpretation and usage of pharmacometric simulations and intervals;Journal of Pharmacokinetics and Pharmacodynamics;2022-08-04

3. Assessment of pharmacokinetic linearity after repeated drug administration;Pharmaceutical Statistics;2022-03-17

4. Recurrent events modelling of haemophilia bleeding events;Journal of the Royal Statistical Society: Series C (Applied Statistics);2021-01-07